ExamI2:INSGI318/INSG318I(NewI2024/I
2025IUpdate)IPharmacologyI|IGuideIwithI
QsI&IAsI|I100%ICorrect|IGradeIAI
(VerifiedIAnswers)-IGCU
QUESTION
Bethanechol
Answer:
IUrecholine
QUESTION
classificationIofIbethanechol
Answer:
ICholinergicIAgonist:IParasympathomimetic
QUESTION
BethanecholIMOA
Answer:
IstimulatesIcholinergicIreceptors,IwhichIcausesIcontractionIandIemptyingIofItheIurinary
Ibladder.IIncreasesIGIIsecretionsIandIperistalsis,Icon-
IstrictionIofItheIpupilIandIbronchoconstriction
QUESTION
uses/therapeuticIeffectsIofIbethanechol
,Answer:
IToItreatIurinaryIretentionIandIneu-IrogenicIbladderI(non-obstructedIurinaryIretention)
QUESTION
sideIeffectsIofIbethanechol
Answer:
IBlurredIvision,IGIIeffects,IUrinaryIfrequencyIandIurgency,IBronchoconstriction,IN/V/
D,IabdominalIcramps,Ihypersalivation,Isweating,IHA,Idizziness,Iflushing
(SLUDGE:ISalivation,ILacrimation,IUrination,IDefecation,IGIIupset,IEmesis).
QUESTION
adverseIeffectsIofIbethanechol
Answer:
Itachycardia,Iweakness,Ibronchospasm
QUESTION
contraindicationsIofIbethanechol
Answer:
IIntestinalIandIurinaryItractIobstruction,IIBS,IpepticIulcer.ISevereIbradycardia,Ihypotens
ion,ICOPD,Iparkinsonism,Ihyperthy-Iroidism.ISeizures,IactiveIasthma
QUESTION
drugIinteractionsIofIbethanechol
Answer:
IdecreasesIbethanecholIeffectIwithIantidys-
Irhythmic;IganglionicIblockingIagentsIcauseIsignificantIhypotensionIfollowingIsevereIa
bdominalIsymptoms.IFalseItestIresultsI(amylaseI&Ilipase)ImayIresult.IAtropine,Iflavoxa
te,IandIopiatesIcounteractIbethanecholIaction
,QUESTION
labIinteractionsIofIbethanechol
Answer:
IincreasesIAST,Ibilirubin,Iamylase,Ilipase
QUESTION
nursingIimplicationsIofIbethanechol
Answer:
IbaselineIvitalIsignsI(IFIBPIISILOW,ICAN'TIADMINISTERIDRUGS),ImonitorIBPIan
dIHR,IteachIaIpatientItoIriseIslowlyIfromIaIlyingIposition,IauscultateIbreathIsounds,Irec
ordIfluidII&Os,ImonitorItheIpatientIforIpossibleIcholinergicIcrisisI(overdose).IGIVEI1I
hourIbeforeIorI2IhoursIafterImealsItoIminimizeIN/V,IcheckIserumIamylase,Ilipase,IAST
,IbilirubinIlevels.IMonitorIGIIsideIeffects
QUESTION
evaluationIforIeffectivenessIofIbethanechol
Answer:
IevaluateIurinaryIoutput
QUESTION
classificationIofIatropineIsulfate
Answer:
ICholinergicIantagonist:IAnticholinergic
QUESTION
, AtropineIMOA
Answer:
IInhibitsIacetylcholineIbyIoccupyingItheIreceptors;IincreasesIHRIbyIblockingIvagusIsti
mulation;IpromotesIpupilIdilationIandIblockingIirisIsphincterImuscle
(AtroPINEIisItheItramPOLINEItoIgetIyourIHR^)
I
QUESTION
uses/therapeuticIeffectsIofIatropineIsulfate
Answer:
IPre-operativeImedicationItoIre-
IduceIsalivationISOITHATIYOUIDON'TIASPIRATE,IincreaseIheartIrateIforIbradycar-
Idia,IandIdilateIpupilsIforIdiagnosticIexams
QUESTION
sideIeffectsIofIatropineIsulfate
Answer:
IdryImouth,Iconstipation,IdryIskin,IblurredIvision,Iphotophobia,IurinaryIretention
QUESTION
adverseIeffectsIofIatropineIsulfate
Answer:
Itachycardia,IparadoxicIbradycardia,Ihy-
Ipertension,Ihypotension,Iangina,IpulmonaryIedema,Iseizures.IDysrhythmias,Ilaryn-
Igospasm,IStevens-JohnsonIsyndrome,Icoma
QUESTION
contraindicationsIofIatropineIsulfate
